Archives of Obesity and Metabolism (비만대사연구학술지)

The Study of Obesity and Metabolic Syndrome, KAFM (대한가정의학회 비만대사증후군연구회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Perspectives on Obesity in Children and Adolescents

소아청소년 비만의 임상적 이해

  • Kyung Hee Park (Department of Family Medicine, Hallym Sacred Heart Hospital)
  • 박경희 (한림대학교 성심병원 가정의학과)
  • Received : 2024.05.03
  • Accepted : 2024.06.14
  • Published : 2024.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The prevalence of obesity in children and adolescents is increasing worldwide. Obesity in children and adolescents not only increases the risk of transitioning to obesity in adulthood but also increases the risk of cardiometabolic diseases such as high blood glucose, high blood pressure, dyslipidemia, fatty liver, and hyperinsulinemia during childhood. The goal of treating obesity in children and adolescents is not to focus on weight loss but to help children reach a healthy weight while maintaining normal growth appropriate for their age and sex. To achieve this goal, regular physical activity and exercise, dietary modification, improvement of obesity-prone environmental factors, and behavioral changes are required for a healthy lifestyle. If appropriate weight control is not achieved through lifestyle modifications, pharmacotherapy may be considered for adolescents with severe obesity aged 12 and above. Recent clinical trials have reported the efficacy and safety of pharmacotherapy in severely obese adolescents. Currently, two medications can be prescribed in Korea for patients with obesity aged 12 and above: Orlistat and Liraglutide. However, despite effective weight control through drug treatment, body weight may increase again after treatment discontinuation. Therefore, it is crucial to evaluate adherence to health behaviors during visits and continue to educate on lifestyle modifications, even during pharmacotherapy, to minimize weight regain.

Keywords

References

  1. Ministry of Education. Report on school health examination 2023. Seoul: Education Mo.; 2024. 
  2. Bendor CD, Bardugo A, Pinhas-Hamiel O, Afek A, Twig G. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity. Cardiovasc Diabetol 2020;19:79. 
  3. Jebeile H, Kelly AS, O'Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol 2022;10:351-65. 
  4. Kim JH, Yun S, Hwang SS, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr 2018;61:135-49. 
  5. Korea Disease Control and Prevention Agency. Growth calculator [Internet]. Korea Disease Control and Prevention Agency. 2024 [cited 2024 Apr 3]; Available from: https://knhanes.kdca.go.kr/knhanes/sub08/sub08_04.do 
  6. Kang E, Hong YH, Kim J, et al. Obesity in children and adolescents: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr 2024;33:11-9. 
  7. Epstein LH, Wilfley DE, Kilanowski C, et al. Family-based behavioral treatment for childhood obesity implemented in pediatric primary care: a randomized clinical trial. JAMA 2023;329:1947-56. 
  8. Lister NB, Baur LA, Felix JF, et al. Child and adolescent obesity. Nat Rev Dis Primers 2023;9:24. 
  9. Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics 2023;151:e2022060640. 
  10. O'Connor EA, Evans CV, Burda BU, Walsh ES, Eder M, Lozano P. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017;317:2427-44. 
  11. Choe S, Sa J, Chaput JP, Kim D. Effectiveness of obesity interventions among South Korean children and adolescents and importance of the type of intervention component: a metaanalysis. Clin Exp Pediatr 2022;65:98-107. 
  12. Kang NR, Kwack YS. An update on mental health problems and cognitive behavioral therapy in pediatric obesity. Pediatr Gastroenterol Hepatol Nutr 2020;23:15-25. 
  13. Wunsch K, Fiedler J, Hubenschmid S, Reiterer H, Renner B, Woll A. An mHealth intervention promoting physical activity and healthy eating in a family setting (SMARTFAMILY): randomized controlled trial. JMIR Mhealth Uhealth 2024;12:e51201. 
  14. Wang JW, Zhu Z, Shuling Z, et al. Effectiveness of mHealth appbased interventions for increasing physical activity and improving physical fitness in children and adolescents: systematic review and meta-analysis. JMIR Mhealth Uhealth 2024;12:e51478. 
  15. Vidmar AP, Salvy SJ, Wee CP, et al. An addiction-based digital weight loss intervention: a multi-centre randomized controlled trial. Pediatr Obes 2023;18:e12990. 
  16. Stasinaki A, Buchter D, Shih CI, et al. Effects of a novel mobile health intervention compared to a multi-component behaviour changing program on body mass index, physical capacities and stress parameters in adolescents with obesity: a randomized controlled trial. BMC Pediatr 2021;21:308. 
  17. O'Connor E EC, Henninger M, Redmond N, Senger C, Thomas R. High body mass index in children and adolescents: interventions [Internet]. United States Preventive Services Taskforce. 2023 [cited 2024 May 15]; Available from: https://www.uspreventiveservicestaskforce.org/uspstf/index.php/draft-recommendation/high-body-mass-index-children-adolescents-interventions 
  18. Amiri P, Mansouri-Tehrani MM, Khalili-Chelik A, et al. Does motivational interviewing improve the weight management process in adolescents? A systematic review and meta-analysis. Int J Behav Med 2022;29:78-103. 
  19. Kao TA, Ling J, Hawn R, Vu C. The effects of motivational interviewing on children's body mass index and fat distributions: a systematic review and meta-analysis. Obes Rev 2021;22:e13308. 
  20. Kao TA, Ling J, Vu C, Hawn R, Christodoulos H. Motivational interviewing in pediatric obesity: a meta-analysis of the effects on behavioral outcomes. Ann Behav Med 2023;57:605-19. 
  21. Jastreboff AM, Chaplin TM, Finnie S, et al. Preventing childhood obesity through a mindfulness-based parent stress intervention: a randomized pilot study. J Pediatr 2018;202:136-42.e1. 
  22. Davison GM, Monocello LT, Lipsey K, Wilfley DE. Evidence base update on behavioral treatments for overweight and obesity in children and adolescents. J Clin Child Adolesc Psychol 2023;52:589-603. 
  23. Gunnarsdottir T, Njardvik U, Olafsdottir AS, Craighead LW, Bjarnason R. The role of parental motivation in family-based treatment for childhood obesity. Obesity (Silver Spring) 2011;19:1654-62. 
  24. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005;293:2873-83. 
  25. Nikniaz Z, Nikniaz L, Farhangi MA, Mehralizadeh H, Salekzamani S. Effect of Orlistat on anthropometrics and metabolic indices in children and adolescents: a systematic review and meta-analysis. BMC Endocr Disord 2023;23:142. 
  26. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med 2020;382:2117-28. 
  27. Ministry of Food and Drug Safety. Saxenda®pen injection [Internet]. Ministry of Food and Drug Safety. 2017 [cited 2024 Apr 3]; Available from: https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetailCache?cacheSeq=201705815aupdateTs2024-04-03%2015:48:00.0b 
  28. Weghuber D, Barrett T, Barrientos-Perez M, et al. Once-weekly semaglutide in adolescents with obesity. N Engl J Med 2022;387:2245-57. 
  29. Kelly AS, Bensignor MO, Hsia DS, et al. Phentermine/topiramate for the treatment of adolescent obesity. NEJM Evid 2022;1:10.1056/evidoa2200014.